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Transition metals are essential micronutrients for organisms. Excess zinc can be lethal to
bacterial survival. Zinc homeostasis is crucial and is regulated by zinc uptake and efflux system.
Streptococcus pneumoniae AdcR (Adhesin competence regulator) transcription factor is the
member of MarR (multiple antibiotic resistance regulator) family proteins that suppress the zinc
upregulation transporter. In the absence of zinc, AdcR has less affinity to bind DNA and uptake
genes are expressed in order to transport zinc inside the cell. Streptococcus pneumoniae is a
gram-positive human pathogen that is capable of colonizing in the human nasopharynx,
especially in young children and leads to severe diseases including pneumonia, septicaemia, and
meningitis. In this work, we have transformed AdcR gene in E.Coli (BL21D3) cell, and we have
overexpressed and purified AdcR using classical molecular biology and protein purification
techniques. We also performed preliminary biophysical characterization of purified zinc(II)
dependent transcription factor AdcR.
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INTRODUCTION
1.1. General characteristics of Streptococcus pneumoniae
Streptococcus pneumoniae, commonly known as Pneumococcus, was first isolated
simultaneously and independently identified by George M. Sternberg in the United States and by
French Chemist Louis Pasteur in 1881.[1] It was named as Diplococcus pneumoniae from 1920
because it found in pairs and finally in 1974, it was renamed as Streptococcus pneumoniae
because of its similarity to streptococci.[2] Pneumococcus is a Gram-positive, non-spore forming
bacterium that appears usually in pairs or chains, and it behaves differently under aerobic and
anaerobic conditions; hence it has been described as “a facultative anaerobic microorganism”
with an approximately 1 μm diameter cell that has a lancet shape.[3] Furthermore,
Pneumococcus is an α-haemolytic, catalase negative bacterium, which grows exclusively in
complex-media that contains sources of catalase, for example blood.[4] It has a polysaccharide
coated capsule, which varies from strain to strain and based on capsule type approximately 90
different serotypes have been identified so far.[5] The optimum temperature and pH for the
growth and proliferation of Pneumococcus is 37°C and 6.5-7.5, respectively.[6] Genetic material
of S. pneumoniae consists of closed, circular DNA. Depending on the strain, the whole genome
may contain between 2.0 and 2.1 million base pairs including a core set of 1,553 genes.[7] It has
an additional 154 genes in its virulome, which are the main contributor during virulence; in case
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of noninvasive strains, it has 176 genes that maintain noninvasive phenotypic character. The
genomes usually vary around 10 % between different strains.[7]

1.2. Influence on Human Health
Streptococcus pneumoniae is an opportunistic human pathogen that is capable of
colonizing in the human nasopharynx, especially in young children.[8,9] Pneumococcus can live
in the nasopharynx asymptomatically until an event arises, which allows it to spread from the
nasopharynx to different systems and/or body parts, such as the ear, lungs, and meninges where
infections can lead to severe conditions including pneumonia, septicaemia, and
meningitis.[10,11] The migration of pneumococcus typically occurs usually when the immune
system of the host is immature or in immunocompromised individuals, for example children,
HIV infected people, and the elderly are all highly susceptible to Pneumococcus
infections.[12,13] According to World Health Organization (WHO), the world-wide deaths due
to the pneumococcal diseases are approximately 1.6 million, where most affected population are
children with an age below 5 years.[14,15] In some African region over 90 % of children are
considered to be carriers of the disease, and in western societies the values are up to
70 %.[16,17] Acute otitis media, a type middle ear infection that cause inflammation and pain, is
diagnosed in more than 10 million children yearly in the United States, with an estimated annual
cost for treatment of over $5 billion.[18] This single microbe is responsible for approximately
71,000 cases of pneumonia and 1,400 cases of meningitis per year in the USA.[19] Worldwide, it
is estimated there are some 140 million cases of pneumonia per year, and over 50 million cases
for otitis media reported annually.[20]
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1.3. Antibiotics and Vaccines
Since S. pneumoniae is a Gram-positive bacterium, the general treatment for infection are
β-lactam antibiotics, including benzylpenicillin (Penicillin G), ampicillin, cephalosporin C,
ceftriaxone, and aztreonam.[21] However, it is a matter of great concern that bacterial resistance
to antibiotics is increasing day by day. In general, most of the bacteria are capable of genetic
mutation to develop and acquire resistance to antibiotics. Streptococcus pneumoniae resistance to
penicillin was first observed in 1967.[22] A rapid and widespread penicillin and other betalactam resistant strains were observed just a few years later.[23]
There are two different types of pneumococcal vaccines currently available, a
polysaccharide-based and a conjugate vaccination, which are commonly employed to treat
pneumococcal diseases.[24] The main constituent for the polysaccharide-based vaccine is
composed of capsular pneumococcal polysaccharide antigens. The conjugate vaccines are
composed of immunogenic, non-pneumococcal proteins, which are conjugated to individual
pneumococcal polysaccharides. In spite of being quite useful, the polysaccharide-based vaccines
have some disadvantages including limited efficacy for children under 2 years old and the very
old people because their dilapidated antigens.[8] An improvement of vaccine efficacy was
achieved when the polysaccharides were conjugated with proteins in the vaccine.[25] The major
disadvantages of this modified vaccine are that it is very expensive to manufacture and
distribute, and therefore, difficult to implement worldwide to a large population. Moreover, the
vaccine is limited to only that serotype, which have been included in the formulation and does
not have any effect on others. [26]
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1.4. Transcription
As Heraclitus stated, “change is the only constant in life,” where the ability to adapt to
changes will determine successes and failures. In bacteria, the ability to control gene expression
is critical for the keeping intracellular homeostasis under varying environmental conditions,
where the regulation of transcription may play the most important in controlling a bacterium’s
success or failure. Transcription is considered to be the first stage towards controlling cellular
outcomes by regulating the synthesis of a gene products (i.e. proteins) that maintain the cell.[27]
In transcription, a specific component of DNA is copied to mRNA by the enzyme RNA
polymerase. During this operation the DNA sequence is interpreted by an RNA polymerase and
fabricates an antiparallel RNA strand called a primary transcript. This transcript encodes at least
one gene, which may encode for proteins, which produces mRNA (messenger RNA) or
alternatively may cipher for non-coding RNA for example tRNA (transfer RNA), rRNA
(ribosomal RNA), microRNA, or the ribozymes. The mRNAs act as templates for proteins
through translation.[28] This systematic pattern is employed as a staple throughout all three
kingdoms of life, including archaea, bacteria, and eukarya as a fundamental and essential cellular
process.[29]

1.5. Transcription factors
The regulation of transcription is controlled by a series of DNA binding proteins named
transcription factors (TF). TFs control gene expression to adapt to cellular and environmental
conditions. Additionally, other TFs have been implicated in directing cell growth, cell death, and
cell division throughout cell life. [30,31,32] TF’s have a unique feature that they contain at least
one DNA binding domain (DBD), where they bind a specific DNA sequence adjacent to the
4

genes that they regulate. Transcription factors are found in all living organisms as they are
essential for regulation of gene expression. Number of transcription factors in an organism
depends on the size of genome, where typically the larger size genomes have larger number of
transcription factors.[33]
TFs may promote (as an activator) or block (as a repressor) the enrollment of RNAP
(RNA polymerase) to specific gene.[30,31,32] The activation or repression of gene regulation
depends on where the TFs are bind, and how they are triggered.[34] In general the concentration
of RNAP in a bacterial system is low, thus TFs guarantee that RNAP are properly recruited by
contending promoter regions within the genome. Bacterial TFs may have a broad or narrow
control scope. Some TFs, termed global TFs, have the ability to control genes from diverse
functional categories, where they control a wide range of environmental variations. Others target
particular genes of operon, which are referred to as local TFs. [35,36] TFs regulate the
transcription of different genes together with RNAP.

1.6. Transcriptional regulation in S. pneumonia
Streptococcus pneumoniae generally inhabit in the human upper respiratory tract as an
innocuous microorganism, however when it migrates to other tissues pneumococcus must adapt
to these new environmental conditions. In this case, gene regulation is imperative for
Pneumococcus to adapt to the environmental changes including micronutrient concentrations and
other extracellular signals. [37,38]
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1.7. Roles of transition metal ions in bacteria and metal homeostasis
Transition metal ions are essential nutrients for all life. Metal ion cofactors are
indispensable for structural and catalytic roles, which contribute to critical biochemical processes
including respiration, DNA replication, transcription, photosynthesis, response to oxidative
stress, and nitrogen fixation.[39,40,41] Most organisms have a nutritional requirement for firstrow transition metal ions including copper(II), nickel(II), manganese(II), iron(II), cobalt(II) and
zinc(II) ions. Each of these divalent cations coordinate to biomolecules in a similar fashion,
through dative or coordinate covalent bonding interactions. However, due to their electronic
structure each of these metal ions has an energetically more stable coordination geometry, which
is typically described as a preferred coordination geometry. These subtle differences can have a
profound impact on the global biomolecular structure, which impacts both protein stability and in
some cases reactivity. Filling proteins with the wrong metal ion can lead to an erosion of the
biological function related to a particular metal ion homeostasis which often leads to cell
death.[41]
Though transition metal ions are essential for all living organisms, their presence within a
cell can also lead to aberrant reactivity and related toxicity. In bacteria, a metal-responsive
transcription factor generally controls the transition metal ion intracellular concentration by
activating or repressing the expression of particular set of genes. These metalloregulatory
proteins are DNA binding and multimeric, when bind with metals experiencing an allosteric
transition [40, 42, 43].
Metal ions cannot be produced or destroyed, so typically metal ion homeostasis mainly
depends on balancing transport into and out of the cell. Minor changes to the influx and efflux of
metal ions can have lasting impact on the metal ion concentration.[44]
6

1.8. Metal uptake and efflux system of pneumococcus
Streptococcus pneumoniae collects all necessary nutrients for its cellular function and survival
from host body during a colonization or specific bacterial infections.[45] In some cases, bacterial
growth can be dramatically inhibited if bioavailability of metal ions is altered, and often the host
limits nutrients from bacteria as part of the body’s response to inflammation or infection [47, 48,
49]. The concentration of metals in host tissue can differ very drastically in response to
pneumococcal infection. For instance, zinc ion levels in bloodstream elevated at least 10-times
during an infection [50]. To balance the level of metals, pneumococcal uses several types of
transporters and regulators for different metals as shown in Figure 1.1. [ 45,49,51]

Figure 1.1

Summary of the metal uptake and efflux system of S. pneumoinae. Blue color
indicates the several transporters and their substrate, whereas regulators are
indicating in red. [50]
7

1.9. Regulation and Effects of Zinc in Streptococcus Pneumoniae
Zinc(II) is a widespread transition element that is an essential micronutrient for most of the
living organisms.[47, 52] Zn2+ functions as a cofactor for a series of enzymes and it acts as a
structural ion in many other proteins.[53,54] Zinc(II) is the second most abundant trace element
in humans and has a critical effect on the immune system.[55] In the human body, zinc(II) levels
range from 1.5 μM to over 100 μM, and it is estimated to be found in approximately 10 % of all
proteins.[43, 56]In pathogenic bacteria, transcriptional regulators, a subcategory of
metalloregulatory proteins appear to stabilize the zinc(II) levels by controlling zinc(II) uptake
and efflux systems to optimize zinc(II).[30]
One zinc(II)-dependent TF from S. pneumoniae is AdcR, which gains its name from its role as
an adhesin competence repressor. AdcR is the first zinc(II) binding member of the MarR family
of metal-dependent regulators.[57] When there is no metal stress, AdcR has very little affinity
for its DNA operator, and in order to uptake more Zn2+ into the cell downstream genes are
essentially expressed. When the intracellular zinc concentrations increase to a certain degree that
fulfill the Zn2+ sensing position on AdcR, which allosterically triggers the DNA operator binding
by AdcR, consequently represses expression of the metal uptake system [58]. Alternatively, S.
pneumoniae also has SczA, which is a zinc efflux repressor. When Zn2+ is bound, SczA
undergoes a structural change in the DNA binding domain of the protein, which dramatically
increases its affinity of Zn-SczA for its palindrombic DNA binding domain. When Zn-SczA
binds to DNA, it represses the transcription of CzcD a Zn2+ efflux pump protein, which balance
the intracellular free or weekly chelated zinc availability into a level that is required for the cell
Figure 1.2. [58,59]
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Figure 1.2

Zinc(II) homeostasis regulation of Streptococcus pneumoniae. AdcR and SczA are
uptake and efflux regulators and controls the availability of zinc. [58]

1.10. Crystal Structure and function of AdcR
AdcR regulates the ABC transporter genes and transcription of four histidine triad
proteins (PhtA, PhtB, PhtD and PhtE) are also control. [57,60] These proteins are mandatory for
pneumococcal virulence. [61] The Zinc(II) bound state AdcR is triangular in shape and a twofold-pseudosymmetric homodimer, and the structure is similar with the other MarR family
proteins. Protomers of AdcR are similar in structure and both are mirror image of one another
with a deviation of 1.2 Å for the corresponding 129 Cα atoms. The most distinguishable
structural differences between them in the helix-turn-helix (HTH) DNA-binding motif. Highly
α-helical zinc(II)-AdcR consists of 6 α-helix and two antiparallel β-strand. Among the two
functional domains of AdcR, one is dimerization domain consists of α1 helix, C-terminal region
of the α5-helix, and the α6 helix, and another one is HTH DNA binding domain consists of α2,
α3, α4, β1 and β2. Both domains are connected by the long α5 helix, see in Figure 1.3. [61]
9

Figure 1.3

(A) Ribbon representation of crystal structure of the Zinc(II) bound AdcR, where
one protomer colored in yellow and the other colored purple. (B) Zinc binding site
1, where zinc(II) is coordinating by E24, H42, H108 and H112. (C) Zinc Binding
site 2, function is still unknown. [61] structure was reproduced by using PyMol.
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MATERIALS AND METHODS
2.1. Chemicals and Reagents
Deionized water that has been filtered through a Milli-Q water polishing system (18 MΩ
resistivity) was used for all experiments and buffer preparation. All chemicals and reagents used
are commercially available. All glassware was rinsed extensively with deionized water before
use. All media, pipette tips, and tubes used in transformation were previously sterilized.

2.2. Transformation
The vector pATA, which is a pET15b vector containing the S. pneumoniae gene for
AdcR,[62] was transformed into E. coli BL21(DE3) using a 45 s heat shock at 42 oC. Both
pATA and E. coli BL21(DE3) were incubated on ice for 15 minutes. Then 1 µL of plasmid DNA
was transferred into 50 µL of chemically competent cell and mixed gently with a sterile pipette
tip. The mixture was allowed to incubate on ice for another 10 minutes. Then the mixture was
subjected to a hot water bath at 42°C for 45 seconds. After this heat shock, the E. coli BL21DE3
[pATA] was transferred back to the ice bath for recovery (10 to 15 mins.) Then 500 µL of sterile
LB media added to this culture, where it was placed in an incubator/shaker for 1 hr at 200 rpm
and 37 oC. Finally, the E. coli BL21DE3[pATA] was plated on an LB/agar plate inoculated with
100 mg/L ampicillin. This plate was then incubated for overnight at 37 °C, where colonies of this
culture were readily observable.
11

2.4. Overexpression and Purification
2.4.1. Overexpression
E. coli BL21DE3[pATA] cells were used to inoculate a 200 mL sample of sterile LB
media containing 100 µg/mL of ampicillin. This culture was grown with shaking (200 rpm) at 37
°C overnight. The overnight culture was then used to inoculate up to 4 x 1 L LB media
containing ampicillin. Growth of these cultures were then monitored using optical density at 600
nm (OD600) using an OLIS updated Cary14 UV-visible spectrophotometer. IPTG (100 mg/mL)
was added to induced overexpression of AdcR an OD600 between 0.4 to 0.6. After 3 to 4 more
hours, the cells were collected by centrifuge (5000 rpm, 10-15 mins, at 4 °C.) The supernatant
was discarded and cell pellets were collected and preserved at -80 °C until further use.

2.4.2. Purification
The pelleted E. coli BL21DE3[pATA] cells were resuspended in 25 mM Tris buffer also
containing 150 mM NaCl and 5 mM imidazole, which was adjusted to pH 7.4. The cell
suspension was lysed by sonication using with the cell suspension on ice. After sonication, the
lysed cell suspension was centrifuged at 13,000 rpm for 40 minutes at 4 oC, where the
supernatant was collected. A 2% (w/v) streptomycin sulfate solution was added to the
supernatant and continuously stirred for 2 hrs at 4 °C, and the solution was spun at 13,000 rpm
for 10 minutes. Once again, the supernatant was collected and then concentrated in a centrifugal
concentration device with a molecular cut off filter of 10,000 Da. This device was spun at 3,500
rpm until the final volume was less than 10 mL. The concentrated cell extract was loaded into a
Ni-NTA column for purification.
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Purification of AdcR was done using a BIO-RAD DuoFlow FPLC system. The IMAC
Ni-charged resin was purchased from BIO-RAD, and packed in an empty column. The column
was conditioned with Buffer A, which is made up of 25mM Tris buffer containing 150 mM
NaCl, 5 mM imidazole and set at pH 7.4. AdcR was loaded on a ~ 10 mL Ni-NTA column,
conditioned with Buffer A. At a flow rate of 1.0 mL per minute, a linear gradient was established
changing from Buffer A to Buffer B. Buffer B was a 25mM Tris buffer solution, with 150mM
NaCl, 200 mM imidazole adjusted to pH 8.0. When the cell extract was applied to the IMAC Nicharged column, untagged proteins flow through whereas proteins with either a His6 tag placed
at the N- or C-terminus will bind with high affinity to the resin matrix. As Buffer B
concentration increases during the linear gradient, the His6-tagged protein will finally elute
(Figure 2.1).

Figure 2.1

Example of FPLC chromatogram where the initial band represents unbound
protein and the second band represent the target His6-tagged protein AdcR.
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Fractions of eluted protein were collected and reduced the volume using a centrifugal
concentrator device. Protein concentrations were estimated by Bradford assay method. The
purified protein fractions were run on SDS-polyacrylamide gel, where some contaminating
proteins were found along with target protein lane on gel (Figure 2.2).

Figure 2.2

SDS-PAGE gel; lane (1) purified protein fraction, (2-8) Diluted purified protein of
different conc. (9) standard protein marker, others lanes are loaded different lower
concentrations of purified protein.
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2.4.3. His6-tag removal by thrombin cleavage
At this point in time, it is not clear the His6-tags on AdcR will impact their ability to bind
Zn2+ or DNA, so the His6-tags were removed by thrombin cleavage. Initially, purified protein
from the Ni-NTA column was dialyzed to remove imidazole in 25 mM Tris buffer with 150 mM
NaCl at pH 8.0 overnight using a 6-7 KDa MWCO dialysis tubing. After dialysis, 1 U of
thrombin was added. This sample was mixed by inversion at room temperature for 6 hrs. Upon
cleavage of the His6-tag, benzamidine bound to a solid media was added to bind the thrombin,
where the sample spun at 4000 rpm for 10 minutes to removed benzamidine beads and bound
thrombin from the AdcR solution.
To remove the cleaved His6 tags from AdcR, Ni-NTA magnetic beads were used to again
bind the poly-His tag. HisPur Ni-NTA magnetic beads were purchased from Thermo Scientific,
where this medium is made up of immobilized nickel-charged nitrilotriacetic acid (NTA) on a
magnetic particle. Beads can be used manually with a magnetic stand to purify his-tagged
protein. Approximately 100 μL (which contains ~ 100 mg) protein was added into a 1.5 ml tube
along with ~ 100 mg of NiNTA magnetic beads in approximately 500 μL of were placed.
1000μL of equilibration buffer (25 mM Tris buffer with 150 mM NaCl and 5 mM imidazole at
pH 7.4. An equal volume of the solution containing AdcR and the excised His6-tag was added
into the tube, which was very slowly mixed by shaking for 30 minutes. A His6-tag free AdcR
fraction was decanted from this tube once it was placed into a magnetic stand, which bound the
magnetic beads. The His6-tag sample was eluted from magnetic beads by adding 100 μL of 25
mM Tris buffer with150 mM NaCl and 200 mM imidazole at pH 8.0. The beads were then
separated from elution buffer and ready for further use.
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2.4.4. Size exclusion Chromatography
The His6-tag removed AdcR (from herein referred to as just AdcR) was loaded onto a
sephacryl S-200 HR high resolution size exclusion column for further purification. Size
exclusion is usually used to separate the biological molecules such as proteins according to their
molecular weight. Larger proteins elute early where small proteins pass slower. The column was
equilibrated with 2 column volumes of running buffer (25mM Tris buffer with 150mM NaCl at
pH 7.4. An example of a chromatogram from an S-200 separation are shown in Figure 2.3.

Figure 2.3

FPLC size exclusion chromatogram where, AdcR has been annotated. The
absorption was collected at 280 nm during this data collection.

Protein fractions from size exclusion chromatography were concentrated by centrifugation and
subjected to SDS-PAGE to identify the target protein AdcR (Figure 2.4).
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Figure 2.4

SDS-PAGE gel; lane (1) standard protein marker, (2) peak-F, (3) diluted purified
protein fraction peak-E, (4) purified protein fraction peak-E, (5) peak-D, (6) peakB, (7) peak-A and (8) sample that loaded into the column.

2.5. SDS-Polyacrylamide gel electrophoresis
Tris-glycine precast gels were used for SDS-gel electrophoresis and purchased from
NuSep. Loading buffer, running buffer, staining solution and de-staining solutions were prepared
according to well established recipes. [63] The standard protein marker was purchased from
BIO-RAD, Samples and standard markers were loaded into the gel very carefully to avoid cross
contamination.

17

2.6. Protein denaturation experiment
2.6.1. Guanidine hydrochloride denaturation
Fluorescence emission spectra in the presence of different concentrations of guanidine
hydrochloride (GdnHCl) were recorded on an OLIS DM 45 spectrofluorometer at 20 °C. A
quartz cell with a 10 mm light path length and 1 mm light slit width was used with a photon
counting method. [64,65,66] Excitation and emission slits were set at 2 nm and 4 nm,
respectively. Excitation was done at 295 nm, whereas emission spectra was collected from 300
nm to 450 nm. For chemical denaturation studies, 3 μM of AdcR and 3μM of ZnAdcR (~ 15μM
Zn2+) were prepared from 34 μM stock in 25 mM Tris buffer with 150mM NaCl at pH 7.4). The
GdnHCl stock solution was prepared in 25 mM Tris-buffer with 150 mM NaCl at pH 7.4. The
final concentration of GdnHCl was determined by optical refractive index. [73] Twenty-two
different concentration GdnHCl were made from a stock solution. Aliquots of AdcR and
ZnAdcR were added to various concentration of GdnHCl where samples were incubated for ~15
minutes.

2.6.2 Thermal denaturation
To study the thermal stability of AdcR and ZnAdcR, fluorescence emission spectra were
recorded from 10 to 90 °C temperature with 10 °C intervals. Instrumental parameters were the
same as used for the chemical denaturation studies described above. Excitation was done at 295
nm, whereas emission spectra was collected from 300 nm to 450 nm. For chemical denaturation
studies, 25 μM of AdcR and 25μM of ZnAdcR (~ 15μM Zn2+) were prepared from 34 μM stock
in 25 mM Tris buffer with 150mM NaCl at pH 7.4). Proteins samples were incubated for 5
minutes at a specific temperature before a fluorescence data was collected. Reversibility of this
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thermal denaturation was not checked because of sample aggregation that becomes visibly
apparent at 90 °C.

2.7. Preliminary characterization by circular dichroism
General characteristics (confirmation of secondary structure) of AdcR and ZnAdcR were
conducted by OLIS DSM 20 circular dichrometer at 20°C. Data was collected under a constant
atmosphere of N2. The data was collected from samples in a quartz cell with a 10 mm light path
length and 1 mm light slit width. Protein concentrations were 10μM of AdcR and 10μM
ZnAdcR, where both protein samples were supported in a 25 mM Tris buffer with 150 mM NaCl
at pH 7.4.
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RESULTS AND DISCUSSION
The sequence of AdcR from Streptococcus pneumoniae strain D39 and expressed vector
pATA was cloned and confirmed by Thualfequr Al’ Mohanna. [62] The sequence of
recombinant from S. pneumoniae AdcR is as follows:
MGSSHHHHHHSSGLVPRGSHMRQLAKDINAFLNEVILQAENQHEILIGHCTSEVALTNTQEHILMLLSEE
SLTNSELARRLNVSQAAVTKAIKSLVKEGMLETSKDSKDARVIFYQLTDLARPIAEEHHHHHEHTLLTYEQVAT
QFTPNEQKVIQRFLTALVGEIK
After removal of His6-tags using thrombin, the sequence of AdcR :
GSHMRQLAKDINAFLNEVILQAENQHEILIGHCTSEVALTNTQEHILMLLSEESLTNSELARRLNVSQAAVTK
AIKSLVKEGMLETSKDSKDARVIFYQLTDLARPIAEEHHHHHEHTLLTYEQVATQFTPNEQKVIQRFLTALVGEI
K
To compute the different physical and chemical parameters of purified AdcR, the above
sequence was ran in ProtParam tool in ExPasy web server and found the predicted molecular
weight 16887 Da, molar ext. coefficient 2980 M-1 cm-1 and theoretical pI 5.91. [67]
Molecular weight of purified AdcR was determined by SDS-PAGE using the precision
plus protein standard from BIO-RAD. The molecular weight was estimated from the standard
curve of reference proteins which was constructed by plotting log10 molecular weight against
relative mobility of the proteins on gel after electrophoresis. Relative mobility (Rf) of each
protein can be calculated by dividing the distance (in cm) of protein migrated with the distance

20

(in cm) of bromophenol dye front. The estimated molecular weight of the purified AdcR was
found approximately 32 kDa.

Figure 3.1

Estimating the molecular weight of an unknown protein. The linear relationship (r2
> 0.9693) between the proteins’ MW and migration distances demonstrates
exceptional reliability in predicting MW.

Since AdcR is the DNA binding protein, it is difficult remove all tightly bound DNA
from protein. Direct measurement at 280 nm often mis leaded the actual concentration because
of DNA UV absorption at 260 and low molar extinction coefficient of AdcR. So that protein
concentration was measured using Bradford assay method. BSA was used as standard for this
assay method.
As preliminary thermodynamic characterization, a guanidine hydrochloride titration was
performed for both AdcR and ZnAdcR using manual mixing.
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Maximum fluorescence intensity data were sorted out for each concentration of GdnHCl
and normalized. The normalized data were plotted against the GdnHCl concentration to see the
consistency of unfolding with the increasing concentration of GdnHCl (Figure 3.2 & Figure 3.3).

Figure 3.2

Normalized fluorescence Intensity Vs GdnHCl concentration. (A) Apo AdcR
Experiment-1, (B) Apo AdcR Experiment-2, (C) Average of experiment 1&2 with
error bars.
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Figure 3.3

Normalized fluorescence Intensity Vs GdnHCl concentration. (A) Holo AdcR
Experiment-1, (B) Holo AdcR Experiment-2, (C) Average of experiment 1&2 with
error bars.

Many proteins unfold according to two-state model of denaturation. [69,70] Assuming
that AdcR unfolded according to two-state unfolding chemical reaction.
𝑁 ↔𝐷
Above reaction has an equilibrium constant and for a real two-state unfolding equilibrium
constant is related to the free energy (ΔG°). To determine the free energy, we perturbed the
equilibrium by denaturant guanidine hydrochloride (GdnHCl).

We started with,
𝑁

1

𝐹𝑓 = 𝑁+𝐷 = 1+𝐾
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(2.1)

Similarly,
𝐾

𝐹𝑢 = 1+𝐾

(2.2)

Where, 𝐹𝑓 is the fraction of folding, 𝐹𝑢 is fraction of unfolding, N is the native, D is the
denature state of protein and k is equilibrium constant. Now we also know that,
𝛥𝐺° = −𝑅𝑇 𝑙𝑛𝐾
Or

𝐾 = 𝑒𝑥𝑝(−𝛥𝐺°/𝑅𝑇)

(2.3)

ΔG° changes linearly with the increasing GdnHCl and the following equation was used. [24]
𝛥𝐺° = 𝛥𝐺°(𝐻2𝑂) − 𝑚[𝐺𝑑𝑛𝐻𝐶𝑙]

(2.4)

Where, ΔG° is the observed unfolding free energy at a specific GdnHCl concentration,
ΔG°(H2O) is the free energy in the absence of GdnHCl, m is a protein specific positive constant.
Combined all equations with the linear extrapolation model (LEM) we got,
𝐹𝑓(𝑥) =

1
[𝛥𝐺°(𝐻2𝑂)−𝑚𝑥]
−
𝑅𝑇
1+𝑒𝑥𝑝

Iobs = Ff (af x + bu) + (1- Ff) (aux + bu)

(2.5)
(2.6)

Where, Iobs is the observed fluorescence intensity. We fitted these equation in Gnuplot,
where the initial guesses of af,bf, au and bu were 0.001, 1.00, 0.001 and 0.001 respectively. We
found the free energy (ΔG°) of AdcR for both of two experiment were -0.13487 kcal/mol and 1.73199 kcal/mol respectively. On the other hand, ΔG° of ZnAdcR were found -0.5389 kcal/mol
and -1.40082 kcal/mol respectively. We plotted the output data from Gnuplot against normalized
raw data of both AdcR and ZnAdcR to see the deviation of actual data from fit data (Figure 3.4
& 3.5).
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Figure 3.4

Plots of fit data from Gnuplot and normalized fluorescence intensity of ZnAdcR
GdnHCl denaturation

Figure 3.5

Plots of fit data from Gnuplot and normalized fluorescence intensity of AdcR
GdnHCl denaturation

Fluorescence intensity of both AdcR and ZnAdcR are decreasing with increasing
temperature and followed strong linearity (AdcR r2=0.99; ZnAdcR r2=0.98) (Figure 3.6 & 3.7)
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Figure 3.6

Thermal denaturation of AdcR and ZnAdcR; Normalized fluorescence intensity vs
temperature

Figure 3.7

Thermal denaturation of AdcR and ZnAdcR; Linear regression fit of normalized
fluorescence intensity vs temperature

Preliminary confirmation of secondary structure of AdcR was performed by Circular
dichroism and the spectra were recorded from 190 nm to 260 nm. The residual molar ellipticity
were expressed as degree cm2 dmol-1. CD spectral data of both AdcR and ZnAdcR were
analyzed by online software CAPITO (http://capito.nmr.leibniz-fli.de). [71] This CAPITA
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program predicts the secondary structures on the basis of given amino acid sequence via ChouFasman algorithm and CD spectra. [72]

Figure 3.8

Circular dichroism spectra
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Predicted secondary structures of apo and holo AdcR are given in Table 3.2 and Table 3.3 as
follows:
Table 3.2

Predicted secondary structures of Apo AdcR

Secondary structure

Chou-Fasman algorithm

Basis of CD Spectra

α - helix

0.62

0.45

β - strand

0.32

1.00

Irregular

0.06

0.04

Table 3.3

Predicted secondary structures of Holo AdcR

Secondary structure

Chou-Fasman algorithm

Basis of CD Spectra

α - helix

0.62

0.44

β - strand

0.32

0.12

Irregular

0.06

0.23

Previously reported crystal structure of zinc bound state of AdcR in PDB have shown that it
contains 60% of helix and 2% beta strand. [61] Whereas we found 44% of helix and 12% of beta
turn in holo AdcR.
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CHAPTER IV
CONCLUSION
The ultimate goal of this project is to build a thermodynamic profile of AdcR-DNA
interaction by performing several biophysical techniques. An initial effort was made to
successfully transform the cloned pATA vector into the E. coli (BL21D3) competent cell,
overexpress, and purify the AdcR. To limit the zinc uptake can be the target of new candidate
medication for controlling S. pneumoniae.
Secondary structure of AdcR was predicted from the circular dichroism spectra using an
online analysis tool and thevresult was nearer to the previously reported AdcR structure.
Although the thermodynamic results from GdnHCl and thermal denaturation experiments were
not convincing, this initial effort will help the project move forward.
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